News & Updates

Currently available risk scores are unreliable for predicting recurrent atrial fibrillation (AF) after initial radiofrequency pulmonary vein isolation, a new study has found.

While major infections worsen 5-year survival after percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for coronary artery disease, no detrimental effects on mortality are observed thereafter, suggesting that its impact subsides after 5 years, a recent study has found.

Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), carries a significant morbidity risk. Risk factors for VTE include surgery, hospitalization, pregnancy, contraceptive use, older age, overweight, and obesity. Dr Lee Yuh Shan, a haematologist at Gleneagles Hospital and Mount Elizabeth Novena Hospital, Singapore, explains how newer drugs such as apixaban (Eliquis, Pfizer) address the challenges posed by conventional VTE management therapies.

Higher-risk heart failure (HF) patients who show improvements in peak oxygen consumption (VO2) following cardiac rehabilitation (CR) have lower risks of new-onset atrial arrhythmias, mortality, and hospitalization due to HF exacerbation, a recent study has found.

Severe hypoglycaemia is a risk factor for hospitalization and mortality among older patients with diabetes, a study reports. The event may also serve as a marker of future cardiovascular events among those with pre-existing heart disease and obesity.